Nuvalent Inc Earnings

The next earnings date for Nuvalent Inc is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Nuvalent Inc Earnings

Report DateEstimated Earnings Per Share
11/06/2025$-1.36

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Nuvalent Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025---$-1.39-13.93%
05/08/2025---$-1.18-13.88%
02/27/2025---$-1.05-0.02%
11/12/2024---$-1.28-44.19%
08/08/2024---$-0.88-19.21%
05/09/2024Before Market$-0.69-1.47%
02/27/2024Before Market$-0.62-3.33%
11/14/2023Before Market$-0.59-1.72%
08/10/2023Before Market$-0.513.77%
05/11/2023Before Market$-0.4413.73%
03/16/2023Before Market$-0.49-13.95%
11/10/2022Before Market$-0.416.82%
08/10/2022Before Market$-0.387.32%
05/12/2022Before Market$-0.3610.00%
03/29/2022Before Market$-0.36-12.50%
11/10/2021Before Market$-0.39-56.00%
09/08/2021Before Market$-3.17-1,568.42%
06/02/2021---$-0.41---
03/31/2021---$-2.39---
03/31/2020---$0.34---

More About Nuvalent Inc

Country
USA
Full Time Employees
200

Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitors (TKIs) for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC) which is under the Phase 2 portion of the ARROS-1 Phase 1/2 clinical trial; NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under the Phase 2 portion of the ALKOVE-1 clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR that is in Phase 1a/1b clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Nuvalent Inc Earnings” Can Refer to the Nuvalent Inc Earnings Date

Some people say “Nuvalent Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Nuvalent Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Nuvalent Inc Stock on the Earnings Date

If you own Nuvalent Inc stock (NUVL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Nuvalent Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Nuvalent Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Nuvalent Inc Earnings

You can contact us any time if you would like to ask questions about Nuvalent Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.